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Glioblastoma multiforme (GBM) is the most common brain tumor with very aggressive and infiltrative. 
Extracellular matrix (ECM) plays pivotal roles in the infiltrative characteristics of GBM. To understand 
the invasive characteristic of GBM, it is necessary to study cell-ECM interaction in the physiologically 
relevant biomimetic model that recapitulates the GBM-specific ECM microenvironment. Here, 
we propose biomimetic GBM-specific ECM microenvironment for studying mode and dynamics of 
glioblastoma cell invasion. Using tissue decellularization process, we constructed a patient tissue-
derived ECM (pdECM)-based three-dimensional in vitro model. In our model, GBM cells exhibited 
heterogeneous morphology and altered the invasion routes in a microenvironment-adaptive manner. 
We further elucidate the effects of inhibition of ECM remodeling-related enzymatic activity (Matrix 
metalloproteinase (MMP) 2/9, hyaluronan synthase (HAS)) on GBM cell invasion. Interestingly, after 
blocking both enzyme activity, GBM cells underwent morphological transition and switch the invasion 
mode. Such adaptability could render cell invasion resistant to anti-cancer target therapy. There results 
provide insight of how organ-specific matrix differentially regulates cancer cell phenotype, and have 
significant implications for the design of matrix with appropriate physiologically relevant properties for 
in vitro tumor model.
Invasion and dissemination of cancer cells cause migration of neoplastic cells into surrounding tissues, resulting 
in mortality in tumor patients1–3. In particular, cancer cell invasion is of enormous clinical importance, since it 
involves both distant metastasis and local spreading, whereby cancer cells degrade and migrate through the tissue. 
The significance of cancer cell invasion is evident in the glioblastoma multiforme (GBM), which shows infiltra-
tive and rapid growth into the surrounding brain tissue. The invasive and migratory characteristics of GBM cells 
provide a wealth of information about tumors within a patient3.
Three-dimensional (3D) in vitro culture systems are increasingly employed to assess cell-ECM interactions 
and invasion of tumor cells. Indeed, cell behavior and responsiveness are dramatically different in a 3D physio-
logical environment versus two-dimensional (2D) Petri dish conditions4,5. Importantly, in 3D cultures, ECM is 
an essential determinant of the cellular response to invasion and migration processes6. Brain ECM has a distinct 
composition from ECM in other tissues and organs, with a low stiffness and loosely connected cellular net-
work. The ECM component of brain tissues contains high amounts of hyaluronic acid (HA), glycosaminoglycans 
(GAGs), and proteoglycans, but lacks fibrous materials such as collagen, fibronectin, etc7,8.
In fact, the interaction between GBM cells and unique extracellular environment of the brain could impact on 
the invasive characteristics of GBM cells. Accumulated experimental and clinical data demonstrate that invasion 
1Department of Bio and Brain Engineering, KAIST, Daejeon, 34141, Korea. 2Department of Neurosurgery, Brain 
Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Korea. 3Department of 
Pharmacy, College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Republic 
of Korea. Correspondence and requests for materials should be addressed to S.-G.K. (email: seokgu9@gmail.com) 
or P.K. (email: pkim@kaist.ac.kr)
Received: 23 October 2017
Accepted: 21 February 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIeNtIfIC REPORTS |  (2018) 8:4608  | DOI:10.1038/s41598-018-22681-3
of GBM cells is regulated by several environmental mechanisms that facilitate the spread of these tumors9,10. For 
example, the invasion pattern of malignant GBM is associated with distinct anatomic pathways following myeli-
nated fiber tracts and blood vessels4,11. In addition to anatomical and physical aspects, there is accumulating evi-
dence that specific extracellular matrix (ECM) components (such as hyaluronan, vitronectin, and tenascin-C) are 
unregulated at the border of the spreading GBM, and this may alter cellular invasiveness7,10,11. Because molecular 
guidance cues during cell invasion are often dependent on the ECM, the underlying mechanism of glioblastoma 
invasion and the GBM-specific ECM microenvironment represent potential targets for treating GBM.
Despite the significance of a brain-specific ECM microenvironment for understanding GBM cell invasion, 
most culture systems have so far utilized matrix materials (either synthetic or derived from animals)12–15. Such 
systems have limited utility for expanding the use of in vitro models, to enhance the efficiency of anti-cancer drug 
screening or understand the mechanisms of invasion.
To address these issues, we develop a patient tissue-derived decellularized ECM (pdECM) based 3D tumor 
model as a physiologically relevant in vitro system. To show that a patient-derived ECM has impacts on cancer 
cell behaviors, we assessed invasion characteristics of GBM cells within decellularized ECM compared to colla-
gen matrix in vitro, with a specifically focus on morphology and dynamics of invasion. The disseminated GBM 
cells exhibited heterogeneous morphology and invasion mode within ECM but were drastically different within 
the collagen matrix. By blocking ECM remodeling-related enzymatic activities, GBM cells facilitated change in 
the disseminated cell and underwent the alteration of invasion strategy. Our results highlight the potential of 
patient-derived tissue-specific ECM for use in in vitro tumor model.
Results
Characterization of Decellularized Patient-derived Extracellular Matrix (pdECM). To investigate 
cell-ECM interaction and the invasion phenotype of glioblastoma cells, we developed a physiologically relevant 
in vitro 3D tumor models that reconstruct the GBM-specific ECM microenvironment (Fig. 1). We utilized decel-
lularized patient tissue-derived ECM (pdECM) as a matrix material that preserves the complex mixture of in 
vivo ECM components and structures. The pdECM was obtained from GBM patients’ brain tissues (n = 15) via 
decellularizing solution (1% Triton X-100, 0.1% NH4OH). Histological analysis showed that the nucleus and/
or cellular components were removed completely from native tissue. Immunofluorescence analysis indicated 
that ECM components, including collagen IV, fibronectin and laminin, were preserved after decellularization 
(Fig. 2A). DNA content analysis showed that the amount of DNA in pdECM was 8.9% of that in native tissues 
(p < 0.01) (Fig. 2B). The contents of ECM components, including collagen, GAGs, and HA were not significantly 
changed after decellularization (Fig. 2C). After decellularization, pdECM was solubilized by pepsin digestion to 
reconstruct a 3D hydrogel. To promote polymerization of pdECM, we added collagen pre-gel solution (4 mg/ml) 
to a final pdECM solution (20 mg/ml). In that, pdECM-based scaffolds contained 10% collagen of their original 
volume (10: 1, pdECM/collagen; v/v). The pdECM pre-gel solution (pdECM pre-gel) was acidic (pH 2~3) before 
encapsulating the pdGCs. When the pdECM pre-gel was adjusted to physiological conditions (pH 7), it behaved 
like a thermo-sensitive hydrogel. The pH-adjusted pdECM pre-gel was incubated in 37 °C for 0.5 to 1 h, trans-
forming the pdECM pre-gel to hydrogels (Fig. 2D). Scanning electron microscopy (SEM) images showed the 
microscopic structure of the pdECM-based hydrogel. The matrix had a porous and fibrous structure composed 
of nanofibers forming larger microscale fibrils (Fig. 2E). The elastic modulus of each sample was measured under 
oscillation conditions after forming a hydrogel. The average modulus of the pdECM hydrogel is 78.09 ± 29.22 Pa 
(Fig. 2F) that was comparable to that of brain tissue16. We, therefore, conclude that our decellularized pdECM is 
acceptable as a human brain-ECM for in vitro 3D tumor model.
Invasion of pdGCs in pdECM-based three-dimensional (3D) tumor model. We next explanted 
patient-derived GBM cells (pdGCs) into pdECM and developed in vitro 3D tumor models. pdGCs were prepared 
according to previous literature on cell isolation from GBM patient tissues17. Using this model, we explored 
how the ECM microenvironment impacts on the kinetics of cancer cell invasion and dissemination. Figure 3A 
displays representative time-lapse images of the invasive patterns of pdGCs in pdECM. The cells showed high 
invasiveness into the adjacent matrix, and the core of the tumorsphere had spread widely after 3 days. In contrast, 
pdGCs showed relatively limited migration in collagen hydrogel compared to pdECM (Fig. 3). In both pdECM 
and collagen matrix-based tumor models, we observed disseminating cells at the protrusive border that exhibited 
single-cell migration behavior, characterized by a lack of cell-cell interactions. The invading cells showed signifi-
cantly different morphologies depending on the culture matrices. The disseminated cells exhibited heterogeneous 
morphologies, including rounded and elongated shapes (Figs 3 and 4, Movie S1).
Figure 1. Schematic illustration of the patient tissue-derived extracellular matrix (pdECM)-based three-
dimensional (3D) tumor model.
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To investigate this further, we stained a filamentous actin (F-actin) structure of the invaded cell with fluo-
rescent phalloidin (red) (Fig. 3B). We classified and counted these morphologies according to the cell body to 
protrusion ratio (less than 1:1, rounded morphology; other, elongated morphology [data not shown]). F-actin 
rich cellular protrusions (i.e., invadopodia) were seen in pdGCs cultured in collagen matrix rather than pdECM. 
In pdECM, the total number of disseminated cells was approximately 17-fold higher compared to that in col-
lagen (Fig. 4B). Moreover, pdGCs cultured in pdECM exhibited both elongated (58.7%) and rounded (41.3%) 
shapes. In contrast, pdGCs cultured in collagen matrix disseminated in a mesenchymal fashion and appeared as 
elongated cells (91.4%) (Fig. 4C). Thus, the pdGCs cultured within pdECM showed significantly heterogeneous 
morphologies (elongated or rounded shape), single-cell migration behavior and indistinct cellular margins. This 
result is consistent with previous research showing that GBM cells have high morphological heterogeneity18.
To further identify the ECM-dependent invasion dynamics of cells, we performed a cell-tracking analysis. 
In Fig. 4D, the pdGCs showed constant radial dissemination and/or migration into the surrounding matrix in 
a random manner in the pdECM hydrogel, as well as a relatively high migration velocity (0.97 ± 0.06 μm/min) 
(Movie S1d). In collagen matrix, GBM cells migrated and/or infiltrated into the adjacent matrix with a relatively 
slow migration velocity (0.33 ± 0.02 μm/min) and we occasionally observed cells that were slowing down or 
pausing temporarily during migration (Fig. 5A, Movie S1a,b). In some cases, the trajectories of invading pdGCs 
overlapped partially or completely between pdECM and collagen (Fig. 4D; red arrow), which presumably indi-
cates the formation of invasion-tracks generated by front leading cells. The invasion-tracks were more frequent in 
Figure 2. Characterization of patient tissue-derived extracellular matrix (pdECM). (A) Optical and histological 
images of native brain tissue and pdECM. (B) Quantification of DNA content in native brain tissue and pdECM 
(**p < 0.01). (C) Quantification of ECM components (collagen, glycosaminoglycans [GAGs]) in native brain 
tissue and pdECM (n = 4), (*P < 0.05; **p < 0.01). (D) Gelation of pdECM pre-gels solution. (E) Scanning 
electron microscopy image (SEM) of pdECM hydrogel. (scale bar = 100 μm). (F) Mechanical property of 
pdECM hydrogel.
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cells cultured in collagen matrix versus those cultured in pdECM (Movie S1c,e). Our results imply that pdECM 
facilitates the dissemination of pdGCs into the surrounding matrix with high migration velocity (0.97 ± 0.06 μm/
min) and in a random manner.
Next, we assessed whether cell migratory behavior in a single cell level might be different depending on cell 
morphology (Fig. 5, Movie S2). For the elongated morphology type, individual cell trajectories showed high 
directional persistence and the cells spread radially. During the invasion process, the elongated cells exhibited 
directional persistence, that is, sustained migration in the same direction (Fig. 5C). However, for the rounded 
morphology type, cells showed increased tortuosity and a decrease in persistent directional migration (Fig. 5D). 
To further elucidate the dependence of cell-shape on cell invasion behavior, we quantified the migration speed 
and directionality of each cell morphology type. Although there was no difference in the migration speed or total 
distance migrated (accumulated distance), the Euclidean distance (linear distance between the start and end-
point of a cell) showed significant differences between rounded and elongated cell morphology types (Fig. 5E, F). 
Directionality, which describes the orientation of cell migration (Euclidean distance divided by the accumulated 
distance), was significantly increased for the elongated cell morphology type (Fig. 5G). Elongated cells exhibit 
thin and long filopodia, allowing them to move in a directionally persistent manner. Herein, the elongated cells 
exhibited two types of migratory behavior. First, some cells showed discontinuous and saltatory migration, during 
which the cells interact with the pdECM and form thin and long leading protrusions (uni-/bi-directional) in the 
direction of movement. Once a cell forms a leading protrusion, it starts to migrate and shows complete adhesion 
to the surrounding ECM. Afterward, the protrusive edge shrinks rapidly and the cell relocates (Fig. 5A, top, mid-
dle, Movie S2a,b). In addition to saltatory migration, some cells displayed continuous migration (Fig. 5A, bottom, 
Movie S2c). Rounded cells displayed an irregular and rapidly changing morphology, forming poorly defined, 
short protrusions at the leading edge of the cell (Fig. 5A, right, Movie S2d,e,f). These results indicated that there is 
a correlation between the directional persistence of invading cells and the formation of protrusions during migra-
tion. Taken together, we identified cell-shape dependent migration behaviors. Elongated cells formed thin and 
Figure 3. Time-laps invasion image of pdGCs in pdECM-based 3D tumor model. (A) Representative time-
lapse images of invasion by pdGCs into pdECM and collagen matrices (scale bar = 100 μm). (B) Filamentous 
actin (F-actin) staining of pdGCs in pdECM and collagen matrices.
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long filopodia and showed invasion in a persistent direction, while rounded cells exhibited bleb-like structures 
and formed multiple, poorly defined protrusive edges.
Gene expression of pdGCs in pdECM-based three-dimensional (3D) tumor model. Brain ECM is 
composed of typical ECM proteins (ex., laminin, type-IV collagen, and fibronectin) and an HA-enriched matrix 
with associated proteoglycans and glycoproteins. Especially, in malignant GBM, HA contains higher-than-normal 
amounts of brain ECM7,8. Increased HA in GBM promotes the invasive and infiltrative phenotype by activating a 
number of coordinated cellular programs7,10. This raises the possibility that an HA-enriched environment in our 
pdECM-based 3D tumor model might play an important role in pdGCs invasion and facilitate complex inva-
sion phenotypes. Moreover, during tumor progression, tumor cells apparently produce enzymes that destroy and 
remodel the matrix microenvironment, thus permitting invasion into surrounding tissues2,3. We, therefore, ana-
lyzed the encoded HA-related genes and matrix metalloproteinases (MMPs), including the HA-receptor (CD44), 
MMP 1, 2 and 9, hyaluronan synthases (HASs) 1, 2 and 3 and hyaluronidases 1, 2 and 3 (Hyal1/2/3) (Fig. 6). We 
collected mRNA from pdGCs cultured in 2D, collagen, and pdECM environments after 3 days. By quantitative 
real-time (qRT) polymerase chain reaction (PCR) analysis, we identified that MMP1, an enzyme that breaks 
down collagen type 1, was the most highly expressed cell culture within the collagen matrix. CD44, HAS, Hyal1/2 
and MMP9 were significantly increased in pdGCs cultured within pdECM. As we mentioned previously, our 
pdECM contained various components of brain ECM (e.g., HA, GAGs, Col IV, etc.). Therefore, over-expressed 
HAS, Hyal1/2 and MMP9 (Col IV-cleaving MMP) genes might contribute to ECM remodeling during cell inva-
sion. In particular, increased levels of HAS in pdECM resulted in newly synthesized HA that sequentially inter-
acted with surface receptors of GBM cells. Therefore, the up-regulated activity of enzymes, such as HAS and 
MMP, might be correlated with increased invasion of GBM cells in pdECM.
Effects of MMP9 and HAS2 Inhibitors in pdECM-based three-dimensional (3D) tumor model. 
By PCR analysis, we confirmed that MMP9 and HAS2 were highly upregulated in pdGCs cultured within 
pdECM. In fact, both MMPs and HAS have been implicated as playing crucial roles in GBM invasiveness, thus 
Figure 4. pdGCs display complex invasion phenotype in the pdECM-based 3D tumor model. (A) 
Representative images of cellular morphologies in each hydrogel (scale bar = 100 μm). (B) Quantitative analysis 
of disseminated cells count. (C) Quantitative analysis of dissemination distribution by morphological type. (D) 
Cell tracking analysis of pdGCs in each hydrogel.
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causing ECM remodeling19,20. Therefore, we tested inhibitors of MMP2/9 and HAS to confirm the effect of those 
genes on cells with heterogeneous modes of invasion. The proliferation of pdGCs in the presence of an MMP 
inhibitor (SB-3CT) was relatively decreased in pdECM compared with a 2D environment at 100 µM, but not 
at 10 µM (Fig. 7A). Moreover, invasion of pdGCs was inhibited by SB-3CT (Fig. 7B, D). Interestingly, dissemi-
nated cells were significantly decreased in number and the morphology of invading cells was changed in pdECM. 
The distribution of morphological cell type dissemination was as follows: elongated, 57.7%; and rounded, 42.3% 
(without inhibition). In the presence of SB-3CT, the proportion of invading cells with a rounded morphology was 
increased in a dose-dependent manner (10 uM, 71.1%; 100 uM, 81.5%) (Fig. 7C, E). Furthermore, zymography 
demonstrated that the expression of MMP2 and MMP9 was slightly downregulated with higher doses of SB-3CT 
(Fig. 7F).
Figure 5. Two distinct invasion strategies in a patient-derived ECM-based 3D culture model. (A,B) 
Representative single-cell trajectory images of pdGCs in pdECM hydrogels (scale bar = 100 μm). (C,D) Cell 
tracking analysis of pdGCs by cellular morphology in pdECM hydrogel. (E) Velocity profiles of pdGCs by 
cellular morphology in pdECM hydrogels. (F) Difference between accumulated and Euclidean distances 
by cellular morphology in pdECM hydrogels (*p < 0.05). (G) Directionality of invading pdGCs by cellular 
morphology in pdECM hydrogels (**p < 0.01). (H) Representative images of pdGC distribution (F-actin) in 
pdECM hydrogels (scale bar = 50 μm).
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Next, we tested the effect of HAS inhibition on pdGCs invasion. 4-methylumbelliferone (4-MU) is an inhib-
itor of HA synthesis that blocks the production of HA components (and where glucuronic acid is a major com-
ponent). We analyzed the proliferation rate and invasion of pdGCs after 4-MU treatment (0.1, 1 mM) for 72 h 
(Fig. 7G, J). pdECM displayed more resistance to 4-MU at 0.1 mM (proliferation rate: 78.45%), while there was 
no culture condition-dependent effect at a high concentration (1 mM). Interestingly, in the presence of 4-MU, 
the number of disseminated pdGCs decreased in pdECM, but most cells showed a morphological change from 
rounded to elongated (Fig. 7H, I, K). Magnified images of invaded pdGCs revealed elongated and thinner mor-
phologies in a dose-dependent manner in pdECM (Fig. 7K). The molecular profiles of 4-MU-treated pdGCs were 
correlated with HAS inhibition (Fig. 7L), HAS expression was decreased in a dose-dependent manner. MMP2 
and Hyal2 expression were significantly decreased, but there was no change in Hyal3 expression. Interestingly, 
MMP1 and MMP9 expression were significantly increased. These results suggest that inhibition of HAS promotes 
an alternative invasion strategy mediated by MMP.
On the other hands, such plasticity of cell invasion under enzymatic activity inhibition did not observe in the 
pure collagen matrix (Supplementary Figure 2). Although cells treated MMP inhibitor (0.1 mM) exhibited mor-
phological change similar to the cells in pdECM, HAS inhibition did not provide the morphological change even 
at the high concentration. Therefore, we supposed that cells cultured in the collagen matrix is more sensitive and 
less resistant to these inhibitors than cells in pdECM.
Discussion
Various methods have been used to study cell migration in GBM, such as 3D in vitro culture models, organo-
typic brain slice cultures, and in vivo mouse models have demonstrated different aspects of GBM invasion and 
migration21,22. In particular, 3D in vitro models have been developed extensively because such models offer a 
more precise and controlled environment, by modifying the properties of ECM. Although previously mentioned 
studies have provided insight into the phenotypic and invasive characteristics of GBM when cultured in 3D 
matrices, such as collagen I, Matrigel23,24, or chemically functionalized HA13,21, these matrices may not completely 
recapitulate the GBM-specific ECM microenvironment. Moreover, most in vitro studies, although demonstrating 
mesenchymal-type invasion in 3D models, typically fail to represent the heterogeneity and complexity of human 
tissue contexts sufficiently18,25.
Our decellularized pdECM-based 3D tumor model could recapitulate the specific ECM microenvironment of 
a GBM patient, including biochemical and biophysical characteristics. Using our model, we elucidated the impact 
of the ECM microenvironment on cell invasion. We found that pdGCs were more invasive and showed heter-
ogeneous shapes, with elongated (58.7%) and rounded (41.3%) morphologies in pdECM hydrogels. In GBM, 
overexpressed HA and CD44 promote the invasive and infiltrative phenotype by activating a number of coordi-
nated cellular programs7,10,20,26. From the characterization of pdECM, we identified that pdECM contains various 
ECM components such as HA and GAGs, which are the main component of the brain. Moreover, ECM-related 
genes including CD44 are unregulated in pdECM. These results show that HA-rich components in pdECM could 
influence invasion characteristics of pdGCs.
Interestingly, the different morphologies are accompanied by different migration trajectories and behaviors. In 
general, cancer cells that move through an ECM can be distinguished by invasion mode (two types). Mesenchymal 
mode relies on proteolytic degradation of the matrix; invading cells with a mesenchymal-like invasion show 
polarized extension of the leading edge of the cell in the direction of migration, as well as a spindle-shaped, elon-
gated morphology2. Rounded cells show a more amoeboid mode of invasion, frequently is accompanied by cell 
blebbing and multiple or poorly defined protrusive cell edges. In the amoeboid mode, cells tend to migrate in the 
absence of proteolytic ECM degradation and to squeeze through the ECM space2,27. The morphology of invading 
cells accentuates direction of the protrusion as an important determinant of invading directionality. Provided 
that protrusion and adhesions formed by polarized cells are themselves directionally continuous, invading cells 
directionality will be continuous. Moreover, poorly defined protrusion or increased numbers of protrusion can 
bring on randomized migrati on28–30. Elongated pdGCs with long leading edge protrusions (uni-/bi-directional) 
showed directionally persistent migration. In contrast, rounded cells moved in a more random manner, having 
poorly defined protrusions or membrane blebbing-mediated movement.
Figure 6. Quantitative polymerase chain reaction (qPCR) analysis of pdGCs in different ECM 
microenvironments. qPCR analysis of the expression levels of ECM-related genes in 2D, collagen and pdECM 
hydrogels (n = 3~5; Asterisks indicate a significant difference statistically by ANOVA (*p < 0.05; **p < 0.01)).
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It is well-known that ECM-related enzymes that degrade and synthesize the ECM are essential for tumor 
progression and in particular invasion2,3,6. According to our results, the ECM-related gene expression profiles of 
pdGCs cultured our 3D tumor models clearly depend on the ECM microenvironment (Fig. 6). Indeed, there is 
a close correlation between the enzymatic activities related ECM remodeling process and cell morphology (i.e., 
migration mode) during the invasion.
Figure 7. Influence of the ECM microenvironment on changes in response to various inhibitors in pdGCs. 
(A) The normalized viability of pdGCs in the presence of an inhibitor of matrix metalloproteinases 2 and 
9 (MMP2/9; SB-3CT). (Asterisks indicate a significant difference statistically by student t-test, *p < 0.05; 
**p < 0.01). (B) Quantitative analysis of disseminated cells the in the presence of SB-3CT (n = 3~4; Asterisks 
indicate a significant difference statistically by ANOVA, *p < 0.05; **p < 0.01). (C) Quantitative analysis of the 
distribution by morphological type in the presence of SB-3CT. (D) Representative image of SB-3CT-treated 
pdGCs in pdECM hydrogels after 72 h invasion. (E) Magnified immunofluorescent images (F-actin) of invasion 
of pdGCs in the presence of SB-3CT treatment. (F) Effect of SB-3CT on pdGCs in pdECM hydrogels MMP-2 
and -9 expression. Gelatin zymograms of pdGCs in presence of SB-3CT treatment. (G) Normalized viability 
of pdGCs in the presence of a hyaluronan synthase (HAS) inhibitor (4-MU) (Asterisks indicate a significant 
difference statistically by student t-test, *p < 0.05; **p < 0.01). (H) Quantitative analysis of disseminated 
cells in the presence of 4-MU (n = 3~4; Asterisks indicate a significant difference statistically by ANOVA, 
*p < 0.05; **p < 0.01). (I) Quantitative analysis of the distribution by morphological type in the presence 
of 4-MU. (J) Representative image of 4-MU treated pdGCs in pdECM hydrogels after 72 h invasion. (K) 
Magnified immunofluorescent images (F-actin) of invading pdGCs in the presence of 4-MU treatment (scale 
bar = 100 μm). (L) Molecular expression profiles in presence of 4-MU. (n = 3~4; Different letter indicate a 
significant difference statistically by ANOVA, p < 0.05). The number of independent experiment (cell counting) 
were performed 6 times.
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In addition to the co-existence of heterogeneous phenotypes of invasive pdGCs, we observed a morpholog-
ical transition in each phenotype by blocking specific enzymatic activity. In our previous report, we demon-
strated that ECM microenvironmental adaptation could allow a flexible invasion strategy for GBM cells cultured 
within a hyaluronic acid (HA)-rich 3D matrix. However, blockade of HAS-mediated invasion route was replaced 
by FAK-mediated invasion following degradation by MMPs12. Therefore, we hypothesize that mesenchymal- 
and amoeboid-like invasive strategies might display different enzymatic interactions with the surrounding 
matrix so that alterations influencing these interactions could lead to phenotypic transitions. In particular, the 
patient-derived ECM consists of HA, and the cells cultured in the pdECM could over-express HA-related genes 
(Hyal1/2, HAS2, CD44) and MMP9. Therefore, the role of enzymatic activities in cell invasion can be relevant for 
the heterogeneous invasion strategy in GBM cell invasion.
To confirm the effect of MMP- and HAS-mediated invasion on heterogeneous invasion characteristics, we 
tested SB-3CT (MMP2/9 inhibitor) and 4-MU (HAS inhibitor). Both inhibitors suppressed the proliferation and 
dissemination of GBM cells. For the MMP2/9 inhibitor, the disseminated cell type was mainly rounded, whereas, 
for the HAS inhibitor, the elongated morphology was predominant. This indicates that GBM cells can simply 
switch motility mode as an escape mechanism. GBM cell treated MMP2/9 inhibitor, used a rounded-amoeboid 
mode of invasion, due to detour the MMP-mediated invasion. On the other hand, inhibition of HA synthases 
(HAS) promoted the morphological transition from a rounded-amoeboid to elongated-mesenchymal morphology. 
In addition to this morphological change, in the quantitative PCR (qPCR) analysis, HAS family expression was 
significantly reduced but the expression levels of MMP1 and MMP9 were increased. According to our results, it 
appears that MMP-mediated proteolysis of the cell cultured in pdECM plays a major role in GBM cell invasion by 
the elongated-mesenchymal phenotype, while HAS-mediated cell migration facilitates rounded-amoeboid phe-
notype in GBM cell invasion. Presumably, newly synthesized HA can induce local hydration of ECM and create 
spaces through which GBM cells may migrate and invade in an amoeboid manner. Therefore, our results indicated 
that GBM cells alter their invasion route to achieve aggressive motility in a 3D microenvironment. Consequently, 
because GBM cells rapidly change their migratory mode according to the specific environment, therapeutic block-
age of one mechanistic pathway may trigger alternative mechanisms of invasion and thus lead to resistance.
Our approach to recapitulate physiologically relevant ECM microenvironment in tumor model utilizes a 
conventional decellularization method to obtain organ-specific ECM components. Other methods of construc-
tion of in vitro brain tumor model have been reported, including HA-collagen interpenetrating network (IPN) 
hydrogel12, HA incorporated gelatin and poly(ethylene glycol) (PEG) based hydrogel13, and methacrylated-HA 
hydrogel21. Unlike these matrices, using decellularized patient-derived ECM provides a more relevant microen-
vironment with major components of brain tumor ECM (HA, GAG, and other ECM proteins), as well as the 
microarchitecture. Our results show the effects of patient-derived ECM to facilitate the invasion and dissemi-
nation and also demonstrate the alteration of invasion strategy by blocking major enzymatic-activity for ECM 
remodeling. Thus we believe that organ-specific ECM-based 3D tumor models could provide a better under-
standing of cancer cell-ECM interactions and inform the choice of ECM-targeted therapeutic options.
Materials and Methods
Preparation of pdECM & pdECM Hydrogel Formation. All patients provided written informed con-
sent, and permission for specimen sampling and evaluation was obtained from the Institutional Review Boards 
at our institutes (Yonsei University Health System, Severance Hospital, Institutional Review Board (4-2014-
0649), The Collaborative Institutional Training Initiative (CITI) Program at the University of Miami (K-2014-
13752477)), as specified in the Declaration of Helsinki. Human brain tissues were freshly obtained from the 
operation room (Severance Hospital, Yonsei University College of Medicine) during the transcortical approach 
for surgery. Patient tissues were cut into small pieces (3 mm × 3 mm × 3 mm). Subsequently, to remove the cel-
lular component from patient derived brain tissues decellularizing solution (0.1% (v/v) ammonium hydroxide 
(Sigma-Aldrich, St. Louis, MO, USA) and 1% (v/v) Triton X-100 (Sigma-Aldrich) in distilled water) was treated 
for 2 days. After that decellularized brain tissue-derived brain ECM (pdECM) was washed using distilled water 
to remove the detergent solution and cellular residue. Finally, pdECM was lyophilized and stored at −20 °C until 
use. For the subsequent experiment, lyophilized pdECM was ground and then enzymatically digested with pepsin 
(1 mg/ml; Sigma-Aldrich) in HCl (0.01 N; Sigma-Aldrich) for 2 days at room temperature until visible ECM par-
ticle disappeared. The final concentration of the pdECM solution was 20 mg/ml. To make hydrogels, the pdECM 
solution was mixed with 10× PBS, dilute to the desired final concentration (20 mg/ml) with ice-cold distilled 
water and adjust to neutralize pH (7.0) by NaOH (1 M; Sigma-Aldrich). After that, the pdECM solution was 
blended with collagen solution (4 mg/ml; BD biosciences, Franklin Lakes, NJ, USA) 10:1 (v/v). Finally, the pre-gel 
solution was incubated for 1 hr at 37 °C.
Characterization of pdECM. For histological analysis, native tissue and pdECM were embedded in 
Paraplast (Leica Biosystems, St Louis LLC, Netherlands) and then the sample was sectioned into 5 µm. To check 
the removal of cellular components and general structure of tissues, sectioned samples were stained with hema-
toxylin and eosin (H&E). Permanently, mounted slides were observed and photographed using a microscope 
equipped with a digital imaging system (DP72, Olympus, Tokyo, Japan). The quantification of DNA content in 
pdECM was determined by DNA extraction kit (Bioneer, Daejeon, Korea) and measuring the DNA concentration 
by ND-1000 Spectrophotometer (Thermo Scientific, Wilmington, USA). To determine the content of GAGs in 
pdECM and native tissue, 1,9-dimethyl methylene blue (DMMB) (Sigma-Aldrich) assay was used as previously 
described31. The HA content in the pdECM and native tissue was quantified by carbazole assay as previously 
described32. The collagen content in the pdECM and native tissue was quantified by hydroxyproline assay as pre-
viously described33. The Bohlin Advanced Rheometer (Malvern Instruments, Worcestershire, U.K.) was used for 
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characterization of the mechanical properties of pdECM hydrogels. The rheological features of pdECM hydrogels 
were measured in a frequency sweep mode. The storage modulus (G’) and loss modulus (G”) of the pdECM 
hydrogel were recorded at a given 1% strain. The elastic modulus of pdECM hydrogels was calculated at 1 Hz.
Cell culture. Tumorspheres (TS) were directly established from fresh GBM tissues as approved by the insti-
tutional review board of Severance Hospital, Yonsei University College of Medicine (4-2012-0212). For isolation 
of TS from GBM specimens, we followed previously published methods for TS isolation from human brain17,34. 
The patient-derived GBM cells (pdGCs; TS) were isolated and cultured in 2D, collagen hydrogel, and pdECM 
environments, respectively. For culture, pdGCs (TS13-20) were cultured in complete TS media composed of 
DMEM/F-12 containing B27 supplements (1×; Invitrogen, San Diego, CA, USA), 20 ng/ml of basic fibroblast 
growth factor (bFGF; Sigma-Aldrich), 20 ng/ml of epidermal growth factor (EGF; Sigma-Aldrich), and 50 U/ml 
penicillin, 50 mg/ml streptomycin.
Invasion assay. The polydimethylsiloxane (PDMS)-based microwells (diameter and depth of microwells: 
6 mm and 500 μm) was utilized for invasion assay. PDMS microwells were treated with poly (ethyleneimine) (1%; 
Sigma-Aldrich) solution for 10 minutes followed by glutaraldehyde (0.1%; Sigma-Aldrich) for 30 minutes and 
then washed overnight with PBS (Invitrogen) to create a matrix-adherent surface. For evaluating the invasive 
ability, the pdGCs were embedded within pdECM hydrogels (10:1 ratio (v/v) with collagen) for 72 hours. The 
dynamic invasion of pdGCs was monitored using an inverted confocal laser-scanning microscope (Ti-E; Nikon, 
Tokyo, Japan), by whole depth of 3D platform. The live images of pdGCs in the 3D matrix were obtained using the 
confocal microscope (Nikon). Subsequently, the live images were analyzed using NIH ImageJ imaging software 
(NIH ImageJ; National Institutes of Health, Bethesda, MD). Each experiment repeated over the 10 times.
Immunocytochemistry. pdGCs that cultured in collagen and pdECM environments for 72 hours were fixed 
in 4% paraformaldehyde (PFA). After fixation with PFA, pdGCs were permeabilized with Triton X-100 (0.3%.; 
Sigma-Aldrich) F-actin was stained with rhodamine-conjugated phalloidin (Sigma-Aldrich) for 1 hr and nucleus 
was stained with DAPI (Sigma-Aldrich) for 5 minutes. And then the samples were washed with PBS and mounted 
with Prolong® Gold Antifade Reagent (Molecular Probes, Oregon, USA). Samples were observed using a confocal 
microscopy equipped with a digital imaging system (Nikon).
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR). After 3 days, the gene expression 
of fully-invaded TSs within biomimetic environment was examined with qRT-PCR. Total RNA was extracted 
from each sample (at least n = 6 per each group) according to conventional RNA extraction protocol. Briefly, 
the samples were prepared with RNA isolation reagent and extracted with chloroform after 10 min, 14,000 rpm 
centrifugation. Reverse transcription was carried out using the cDNA Synthesis kit (Bio-rad, Richmond, CA, 
USA). qRT-PCR was performed using a PCR System (Bio-rad) with PCR Master Mix (Toyobo, Osaka, Japan). 
Gene expression of each marker was quantified using signal amplification of SYBR green (Bio-rad) for CD44, 
hyaluronidase (HYAL) 1, 2, 3, hyaluronan synthase (HAS) 1, 2, 3, matrix metalloproteinase (MMP) 1, 2, 9 and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The level of gene expression was determined with the 
comparative Ct method in which the target genes were normalized to the endogeneous reference (GAPDH). The 
forward/reverse sequences of primers used for experiments was listed in Table 1.
Cell viability assay. Effects of drug (4-MU, SB-3CT) on the survival of pdGCs were determined by WST-1 method 
(Roche Diagnostics, Mannheim, Germany). Briefly, pdGCs cultured in invasion assay platform were incubated with 
the WST-1 solution. After incubated samples at 37 °C for 3 h, the absorbance (O.D.) was measured at 450 nm using a 
microplate reader (Bio-rad). The viability was measured using the absorbance, compared to control group.
MMP zymography. The SB-3CT treated pdGCs media was mixed with sample buffer and loaded with-
out boiling to a 10% polyacrylamide gel (Bio-rad) containing gelatin (1 mg/ml; BD biosciences) and 0.1% SDS 
(Sigma-Aldrich). After electrophoresis, the gels were incubated in renaturing buffer (Thermo Fisher, Waltham, 
MA, USA) at room temperature for 0.5 hr and then incubated in developing buffer (Thermo Fisher) at room 
temperature for 16hr. MMP activity was visualized by staining with Coomassie Brilliant Blue R-250 (Bio-rad).
Gene Forward primer (5′ → 3′) Reverse primer (3′ → 5′)
GAPDH GTATGACAACAGCCTTCAAGAT AGTCCTTCCACGATACCAAA
CD44 CTCTCTCCCTCCACTTCAC GCCTAATGTCCAGTTTCTTTCA
HAS1 GGTGGGGACGTGCGGATC ATGCAGGATACACAGTGGAAGTAG
HAS2 GTGGATTATGTACAGGTTTGTGA TCCAACCATGGGATCTTCTT
HAS3 CTCTACTCCCTCCTCTATATGTC AACTGCCACCCAGATGGA
HYAL1 CATCAAGGAGTATATGGACAC T CAGGGTTAAGGAGGAGGA
HYAL2 GATTACCTGACACGGCTG GAAACTGTTGGTGCTGAGA
HYAL3 TTTCCCTGCTGCCACTTT CTTGGGAGGGTTGACTGTAA
MMP1 AGCTAGCTCAGGATGACATTGATG GCCGATGGGCTGGACAG
MMP2 GACGGTAAGGACGGACTC ACTTCACACGGACCACTT
MMP9 TGGGCTACGTGACCTATGACAT GCCCAGCCCACCTCCACTCCTC
Table 1. Primer sequences used in qPCR analysis.
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Statistical analysis. Data are presented as the mean with standard deviations (SD). Level of significance for 
comparisons between each sample was calculated by using one-way analysis of variance, followed by Student’s 
t-test. A significant difference in statistics was considered at p < 0.05.
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